# Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)

> **NCT07124351** · PHASE4 · RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- Gastrointestinal Cancer
- Gastric Cancer
- Esophageal Cancer
- Appendiceal Cancer

## Interventions

- **DRUG:** CYTALUX™ (pafolacianine)

## Key facts

- **NCT ID:** NCT07124351
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-05
- **Primary completion:** 2026-08
- **Final completion:** 2026-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07124351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07124351, "Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07124351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*